EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

STAT3 regulates 5‐Fu resistance in human colorectal cancer cells by promoting Mcl‐1–dependent cytoprotective autophagy

Yuanyi Yue, Qiang Zhang iD, Xueqing Wang, Zhengrong Sun

Cancer Science · 2023

DOI: 10.1111/cas.15761 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cancer Science, 2023. Verfasst von Yuanyi Yue und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastroenterology, Shengjing Hospital of China Medical University, Shenyang, China. Hauptthemen laut MEDLINE: Colorectal Neoplasms. Die Arbeit wurde bisher 28-mal zitiert (Crossref) und nennt 51 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Chemoresistance to 5‐fluorouracil (5‐Fu)‐based chemotherapy is one of the primary reasons for the failure of colorectal cancer (CRC) management. STAT3 can mediate tumor drug resistance through a variety of diverse mechanisms. Nonetheless, the underlying mechanisms of STAT3‐induced 5‐Fu resistance in CRC are still poorly understood. Here, we aimed to investigate the potential mechanism(s) of STAT3‐induced 5‐Fu resistance in CRC. Quantitative RT‐PCR and Western blot were used to test the expression of STAT3 and Mcl‐1 in chemosensitive and chemoresistant CRC tissues and cell lines. After overexpression or knockdown of STAT3 or Mcl‐1, and/or treatment with or without 5‐Fu or chloroquine (CQ), we tested cell viability, inhibitory concentration 50% (IC 50 ) value of 5‐FU, cell apoptosis, proliferation, migration, and autophagy. STAT3 and Mcl‐1 were significantly upregulated in the chemoresistant CRC tissues and cell lines, and STAT3 positively regulated Mcl‐1. Functional studies demonstrated that STAT3 promoted 5‐Fu resistance in CRC. Mechanistically, STAT3 triggered autophagy via Mcl‐1 to induce cancer chemoresistance. Our results show that STAT3 regulates 5‐Fu resistance in CRC by promoting Mcl‐1–dependent cytoprotective autophagy. Our results provide a novel role of STAT3 and may offer a new approach for managing CRC 5‐Fu resistance.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Colorectal NeoplasmsHumansCell Line, TumorFluorouracilDrug Resistance, NeoplasmApoptosisAutophagyCell ProliferationSTAT3 Transcription Factor

Stichwörter der Autor:innen

5-fluorouracilMcl-1STAT3colorectal cancercytoprotective autophagy

Substanzen

FluorouracilSTAT3 protein, humanSTAT3 Transcription Factor

Autor:innen und Institutionen

  • Department of Gastroenterology, Shengjing Hospital of China Medical University, Shenyang, China.
  • Department of Pulmonary and Critical Care Medicine, Shengjing Hospital of China Medical University, Shenyang, China.
  • Department of BioBank, Shengjing Hospital of China Medical University, Shenyang, China.

ORCID-Profile: Qiang Zhang

Zitieren

APA

Yue, Y., Zhang, Q., Wang, X., & Sun, Z. (2023). STAT3 regulates 5‐Fu resistance in human colorectal cancer cells by promoting Mcl‐1–dependent cytoprotective autophagy. Cancer Science. https://doi.org/10.1111/cas.15761

Vancouver

Yue Y, Zhang Q, Wang X, Sun Z. STAT3 regulates 5‐Fu resistance in human colorectal cancer cells by promoting Mcl‐1–dependent cytoprotective autophagy. Cancer Science. 2023. doi:10.1111/cas.15761

BibTeX
@article{Yue2023,
  author = {Yue, Yuanyi and Zhang, Qiang and Wang, Xueqing and Sun, Zhengrong},
  title = {STAT3 regulates 5‐Fu resistance in human colorectal cancer cells by promoting Mcl‐1–dependent cytoprotective autophagy},
  journal = {Cancer Science},
  year = {2023},
  doi = {10.1111/cas.15761}
}
Kostenlos starten →